BASEL, Switzerland – ( BUSINESS WIRE ) – Polyneuron Pharmaceuticals AG, a clinical-stage developer of a new class of antigen-specific polymers for the treatment of…
29.03.2024
BASEL, Switzerland – ( BUSINESS WIRE ) – Polyneuron Pharmaceuticals AG, a clinical-stage developer of a new class of antigen-specific polymers for the treatment of…